Skip to content

Acute Subcutaneous Defibrillation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01771172
Acronym
ASQ
Enrollment
50
Registered
2013-01-18
Start date
2013-05-31
Completion date
2014-06-30
Last updated
2016-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular Arrhythmias

Brief summary

To assess the defibrillation efficacy of a subcutaneous defibrillation system.

Interventions

None listed

Sponsors

Medtronic Cardiac Rhythm and Heart Failure
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject must be undergoing implant of a commercially approved ICD system * Subject must be willing to provide Informed Consent * Subject must be \> 18 years old

Exclusion criteria

* Subject with impaired kidney function as measured by a glomerular filtration rate (eGFR) estimate \< 29 mls/min/1.73m2 (recorded in the last six months) * Subject has high risk of infection * Subject has EF \< 15% * Subject at high risk of stroke * having a device replacement * Subject with an implanted active non-ICD device, cardiac or non-cardiac (e.g., Neuro stimulator, Pacemaker) * Subject is indicated for CRT * Subject is pacemaker dependent * Subject enrolled in a concurrent study that may confound the results of this study * Subject has medical conditions that would limit study participation * Subject is pregnant * Subject meets

Design outcomes

Primary

MeasureTime frame
Subjects Will Demonstrate a Successful Defibrillation Outcome if They Have 2 Successful Defibrillation Shocks With the Research System.within the first day

Countries

Belarus, Denmark, Netherlands, Slovakia, United Kingdom

Participant flow

Participants by arm

ArmCount
Acute Defibrillation Testing50
Total50

Baseline characteristics

CharacteristicAcute Defibrillation Testing
Age, Continuous57.7 years
STANDARD_DEVIATION 12.3
Sex: Female, Male
Female
12 Participants
Sex: Female, Male
Male
38 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
5 / 50
serious
Total, serious adverse events
9 / 50

Outcome results

Primary

Subjects Will Demonstrate a Successful Defibrillation Outcome if They Have 2 Successful Defibrillation Shocks With the Research System.

Time frame: within the first day

ArmMeasureValue (NUMBER)
Acute Defibrillation TestingSubjects Will Demonstrate a Successful Defibrillation Outcome if They Have 2 Successful Defibrillation Shocks With the Research System.85.7 percentage of success

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026